Literature DB >> 35179552

Association of County-Level Prescriptions for Hydroxychloroquine and Ivermectin With County-Level Political Voting Patterns in the 2020 US Presidential Election.

Michael L Barnett1,2,3, Marema Gaye1, Anupam B Jena4, Ateev Mehrotra4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35179552      PMCID： PMC8980920          DOI： 10.1001/jamainternmed.2022.0200

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic.

Authors:  Andrew I Geller; Maribeth C Lovegrove; Jennifer N Lind; S Deblina Datta; Daniel S Budnitz
Journal:  JAMA Intern Med       Date:  2021-06-01       Impact factor: 21.873

2.  The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Authors:  Leon Caly; Julian D Druce; Mike G Catton; David A Jans; Kylie M Wagstaff
Journal:  Antiviral Res       Date:  2020-04-03       Impact factor: 5.970

3.  Walking the party line: The growing role of political ideology in shaping health behavior in the United States.

Authors:  Mugur V Geana; Nathaniel Rabb; Steven Sloman
Journal:  SSM Popul Health       Date:  2021-10-23

4.  Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.

Authors:  Bhagteshwar Singh; Hannah Ryan; Tamara Kredo; Marty Chaplin; Tom Fletcher
Journal:  Cochrane Database Syst Rev       Date:  2021-02-12
  4 in total
  2 in total

1.  Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications.

Authors:  Yining Hua; Hang Jiang; Shixu Lin; Jie Yang; Joseph M Plasek; David W Bates; Li Zhou
Journal:  J Am Med Inform Assoc       Date:  2022-09-12       Impact factor: 7.942

2.  Ivermectin under scrutiny: a systematic review and meta-analysis of efficacy and possible sources of controversies in COVID-19 patients.

Authors:  Arman Shafiee; Mohammad Mobin Teymouri Athar; Omid Kohandel Gargari; Kyana Jafarabady; Sepehr Siahvoshi; Sayed-Hamidreza Mozhgani
Journal:  Virol J       Date:  2022-06-13       Impact factor: 5.913
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.